Literature DB >> 6340806

Effect of timolol eye drops in subjects receiving systemic propranolol therapy.

P Blondeau, M Côté, L Tétrault.   

Abstract

In a double-blind controlled study seven healthy subjects with normal eyes were given alternatively a placebo or 80 or 160 mg of propranolol per day, with an interval of at least 1 week between the three experiments. Two hours after a dose of the medication was taken, two drops of 0.5% timolol maleate were instilled into one eye, and for the next 4 hours the intraocular pressure, pulse rate and blood pressure were measured hourly. Timolol reduced the intraocular pressure substantially and to the same extent in the subjects who had taken a placebo and those who had taken 80 mg of propranolol per day; however, it had almost no effect in those who had taken 160 mg of propranolol per day. There was marked interindividual variation in the response to timolol. No change in the pulse rate or the blood pressure was noted. A similar study was carried out with 12 patients taking propranolol for various cardiovascular problems; their dosage of this agent was not varied, however. The results were basically the same, except that the patients taking 120 mg of propranolol per day had an intermediate response to timolol.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6340806

Source DB:  PubMed          Journal:  Can J Ophthalmol        ISSN: 0008-4182            Impact factor:   1.882


  1 in total

1.  Ophthalmic drugs as part of polypharmacy in nursing home residents with glaucoma.

Authors:  Matthias Huber; Marita Kölzsch; Ralf Stahlmann; Werner Hofmann; Juliane Bolbrinker; Dagmar Dräger; Reinhold Kreutz
Journal:  Drugs Aging       Date:  2013-01       Impact factor: 3.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.